Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Johnathon N Lakins
Affiliation
University of California san francisco
ORCID
Career Start Year
1992
Papers
46
H Index
30
Expertise
CM4AI Collaborator
Kirsten Obernier (CM4AI)
PMID
Paper Title
Journal Title
Published Year
38017076
Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.
Nat Med
2024
37016139
Author Correction: Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.
Nat Cell Biol
2023
37503095
Tissue tension permits β-catenin phosphorylation to drive mesoderm specification in human embryonic stem cells.
bioRxiv
2023
37322009
A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer.
Nat Commun
2023
35896617
Low lamin A levels enhance confined cell migration and metastatic capacity in breast cancer.
Oncogene
2022
35618935
Screening of organoids derived from patients with breast cancer implicates the repressor NCOR2 in cytotoxic stress response and antitumor immunity.
Nat Cancer
2022
33822843
Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer.
J Exp Med
2021
32721948
Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217.
J Clin Invest
2020
33207224
Mechanical Tension Promotes Formation of Gastrulation-like Nodes and Patterns Mesoderm Specification in Human Embryonic Stem Cells.
Dev Cell
2020
31511693
Controlled modelling of human epiblast and amnion development using stem cells.
Nature
2019
31609314
Patterning the Geometry of Human Embryonic Stem Cell Colonies on Compliant Substrates to Control Tissue-Level Mechanics.
J Vis Exp
2019
29431617
Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma.
Mol Cancer Res
2018
29805991
Genetically Encoded Toolbox for Glycocalyx Engineering: Tunable Control of Cell Adhesion, Survival, and Cancer Cell Behaviors.
ACS Biomater Sci Eng
2018
30202050
A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma.
Nat Cell Biol
2018
29980625
Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells.
J Cell Biol
2018
28381423
Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrix.
Mol Biol Cell
2017
27089513
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.
Nat Med
2016
26342256
Monitoring developmental force distributions in reconstituted embryonic epithelia.
Methods
2016
27820599
Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.
Nat Cell Biol
2016
27452175
Tissue Mechanics Orchestrate Wnt-Dependent Human Embryonic Stem Cell Differentiation.
Cell Stem Cell
2016
25435379
A 3D tension bioreactor platform to study the interplay between ECM stiffness and tumor phenotype.
J Biotechnol
2015
26337386
Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors.
Mol Biol Cell
2015
23770848
Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin.
Oncogene
2014
25030168
The cancer glycocalyx mechanically primes integrin-mediated growth and survival.
Nature
2014
24633304
Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression.
Nat Med
2014
23618955
A physical sciences network characterization of non-tumorigenic and metastatic cells.
Sci Rep
2013
22914951
Exploring the link between human embryonic stem cell organization and fate using tension-calibrated extracellular matrix functionalized polyacrylamide gels.
Methods Mol Biol
2012
20389018
HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.
J Clin Invest
2010
19931152
Matrix crosslinking forces tumor progression by enhancing integrin signaling.
Cell
2009
17911169
alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-kappaB-dependent resistance to apoptosis in 3D mammary acini.
J Cell Sci
2007
16169468
Tensional homeostasis and the malignant phenotype.
Cancer Cell
2005
14691145
Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors.
J Cell Biol
2003
11772027
Evidence that clusterin has discrete chaperone and ligand binding sites.
Biochemistry
2002
12242153
beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.
Cancer Cell
2002
11803476
Expression of multiple forms of clusterin during light-induced retinal degeneration.
Curr Eye Res
2001
11282398
An antigen capture assay for the measurement of serum clusterin concentrations.
J Biochem Biophys Methods
2001
10601611
Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
Oncol Rep
2000
11059746
Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies.
Cancer Res
2000
9774400
Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate.
J Biol Chem
1998
9796610
Clusterin in the male reproductive tract.
J Androl
1998
9336835
Identification and characterization of glycosylation sites in human serum clusterin.
Protein Sci
1997
8723115
Differential display RT PCR of total RNA from human foreskin fibroblasts for investigation of androgen-dependent gene expression.
Am J Med Genet
1996
7672444
5 alpha-Reductase type 1 is localized to the outer nuclear membrane.
Mol Cell Endocrinol
1995
8181474
Molecular characterization of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration.
Eur J Biochem
1994
7680346
Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis.
J Biol Chem
1993
1356648
Active cell death in hormone-dependent tissues.
Cancer Metastasis Rev
1992
1 - 46 of 46
Column Actions
Search
Recommended Authors
Aditya Kumar
Rice University, University of California San Diego
Career Start Year
2013
Number of shared co-authors
1
Kevin M Tharp
University of California berkeley
Career Start Year
2011
Number of shared co-authors
4
Laurent Fattet
Moores Cancer Center, University of California
Career Start Year
2011
Number of shared co-authors
0
Shannon K Alford
National Cancer Institute
Career Start Year
2004
Number of shared co-authors
0
Hon S Leong
University of Toronto
Career Start Year
2002
Number of shared co-authors
0
Trevor D McKee
University Health Network
Career Start Year
2001
Number of shared co-authors
0
Val??rie Petit
INSERM U1021, Institut Curie, PSL Research University, Campus Universitaire
Career Start Year
1999
Number of shared co-authors
0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
1
Michael T Lewis
Baylor College of Medicine
Career Start Year
1996
Number of shared co-authors
2
Kaylene J Simpson
The University of Melbourne, Peter MacCallum Cancer Centre
Career Start Year
1996
Number of shared co-authors
0
Alexander D Borowsky
University of California Davis Health
Career Start Year
1995
Number of shared co-authors
2
Karen H Martin
West Virginia University Cancer Institute, West Virginia University
Career Start Year
1993
Number of shared co-authors
0
Charles A Whittaker
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Career Start Year
1993
Number of shared co-authors
1
Senthil K Muthuswamy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1992
Number of shared co-authors
2
Donna J Webb
Vanderbilt University
Career Start Year
1991
Number of shared co-authors
0
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year
1989
Number of shared co-authors
1
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year
1988
Number of shared co-authors
2
Michael R Freeman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year
1987
Number of shared co-authors
0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year
1986
Number of shared co-authors
0
Charles R Vanderburg
Massachusetts General Hospital and Harvard Medical School
Career Start Year
1986
Number of shared co-authors
0
Beatrice S Knudsen
University of Utah
Career Start Year
1986
Number of shared co-authors
1
Jeffrey L Wrana
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Career Start Year
1985
Number of shared co-authors
0
Rama Khokha
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1984
Number of shared co-authors
0
Simon C Watkins
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year
1981
Number of shared co-authors
0
Mary C Farach-Carson
The University of Texas Health Science Center at Houston School of Dentistry
Career Start Year
1981
Number of shared co-authors
0
Alan Rick Horwitz
Allen Institute for Cell Science
Career Start Year
1977
Number of shared co-authors
0
Anne E Cress
University of Arizona Cancer Center, College of Medicine, University of Arizona
Career Start Year
1977
Number of shared co-authors
0
Kathleen A Burke
Brown University
Career Start Year
1975
Number of shared co-authors
0
Richard O Hynes
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Career Start Year
1970
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Valerie M Weaver
University of California san francisco
Co-authored papers
32
Laralynne Przybyla
University of California san francisco
Co-authored papers
4
Joanna J Phillips
University of California san francisco
Co-authored papers
4
James M Barnes
Center for Bioengineering and Tissue Regeneration
Co-authored papers
4
Jonathon M Muncie
Gladstone Institutes
Co-authored papers
3
Colm Morrissey
Co-authored papers
3
FuiBoon Kai
University of California San Francisco
Co-authored papers
3
Anders I Persson
University of California san francisco
Co-authored papers
3
Russell Bainer
University of California berkeley
Co-authored papers
3
Kirk C Hansen
University of Colorado Anschutz Medical Campus
Co-authored papers
3
Alexander S Barrett
University of Colorado Anschutz Medical Campus
Co-authored papers
3
Ori Maller
Department of Research and Development, Inc.
Co-authored papers
2
Eric A Collisson
University of California san francisco
Co-authored papers
2
Jianping Fu
College of life sciences, Jiangxi Normal university
Co-authored papers
2
Carolyn R Bertozzi
Stanford University
Co-authored papers
2
Barbara L Weber
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Co-authored papers
1
Wadih Arap
Rutgers Cancer Institute of New Jersey
Co-authored papers
1
Peter Kuhn
University of Tubingen
Co-authored papers
1
Catherine C Park
University of California san francisco
Co-authored papers
1
Tyler Jacks
Co-authored papers
1
Jason C Tung
University of California san francisco
Co-authored papers
1
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers
1
Denis Wirtz
Johns Hopkins University
Co-authored papers
1
Joseph E Aslan
Oregon Health & Science University
Co-authored papers
1
Gabriele Bergers
VIB-Center for Cancer Biology
Co-authored papers
1
William A Weiss
University of California san francisco
Co-authored papers
1
Jayanta Debnath
University of California San Francisco
Co-authored papers
1
Kan V Lu
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Co-authored papers
1
Richard Bonneau
Center for Computational Biology (CCB), Flatiron Institute, Simons Foundation
Co-authored papers
1
Shelly Kaushik
Invictus Oncology Pvt. Ltd.
Co-authored papers
1
1 - 30